デフォルト表紙
市場調査レポート
商品コード
1000969

喘息治療薬市場調査レポート:薬剤クラス別(抗炎症薬、気管支拡張薬、および併用療法)、製品別(吸入器、ネブライザー)、投与ルート別-2025年までの予測-2025年までの累積的影響-COVID-19の累積的影響

Asthma Therapeutics Market Research Report by Drug Class, by Product, by Route of administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.81円
喘息治療薬市場調査レポート:薬剤クラス別(抗炎症薬、気管支拡張薬、および併用療法)、製品別(吸入器、ネブライザー)、投与ルート別-2025年までの予測-2025年までの累積的影響-COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の喘息治療薬の市場規模は、2020年の184億369万米ドルから、2025年末までに278億4,979万米ドルに成長すると予測されています。

COVID-19は、未曾有の世界的な公衆衛生上の緊急事態であり、あらゆる業界に影響を及ぼしてきました。この長期的影響は、予測期間中に業界の成長に影響を与えると予測されています。私たちが進めている調査では、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げています。当レポートは、消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19について洞察を提供しています。アップデートされた調査では、COVID-19が市場に及ぼす影響を考慮し、洞察、分析、予測などを提供しています。

当レポートでは、喘息治療薬市場について調査し、市場の概要とともに、薬剤クラス別、製品別、投与ルート別、地域別の動向、COVID-19の累積的影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画作成
    • 実行:調査実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 製品別見通し
  • 薬剤クラス別見通し
  • 投与ルート別見通し
  • 地域別見通し
  • 競合他社別見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 世界の喘息治療薬市場、薬剤クラス別

  • 抗炎症薬
  • 気管支拡張薬
  • 併用療法

第7章 世界の喘息治療薬市場、製品別

  • 吸入器
    • ドライパウダー吸入器
    • 定量吸入器
    • ソフトミスト吸入器
  • ネブライザー

第8章 世界の喘息治療薬市場、投与ルート別

  • 吸入型
  • 経口型

第9章 南北アメリカの喘息治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の喘息治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカの喘息治療薬市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第13章 企業のユーザビリティプロファイル

  • Abbott Laboratories
  • Amgen Inc.
  • AstraZeneca Plc
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • CareFusion Corporation
  • Convexity Scientific Inc
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc.
  • Kare Medical and Analytical Devices Ltd. Co.
  • Merck & Co. Inc.
  • Merxin Ltd
  • Mylan N.V.
  • Novartis AG
  • Parekhplast India Ltd
  • Philips Healthcare
  • Regeneron Pharmaceuticals, Inc
  • Roche Diagnostics
  • Sanofi-Aventis SA
  • Shenzhen Aeon Technology
  • Softhale NV
  • Sunovion Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Trudell Medical Limited (AeroEclipse)
  • Well Lead Medical Co

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL ASTHMA THERAPEUTICS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL ASTHMA THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2026
  • FIGURE 11. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 20. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
  • FIGURE 31. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
  • FIGURE 33. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. CALIFORNIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. FLORIDA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. ILLINOIS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. NEW YORK ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. OHIO ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. PENNSYLVANIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. TEXAS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. GLOBAL ASTHMA THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL ASTHMA THERAPEUTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL ASTHMA THERAPEUTICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ASTHMA THERAPEUTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ASTHMA THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. CALIFORNIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. CALIFORNIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. CALIFORNIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. FLORIDA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. FLORIDA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. FLORIDA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ILLINOIS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ILLINOIS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. ILLINOIS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. NEW YORK ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. NEW YORK ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. NEW YORK ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. OHIO ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. OHIO ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. OHIO ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. PENNSYLVANIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. PENNSYLVANIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. PENNSYLVANIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. TEXAS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. TEXAS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. TEXAS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. GLOBAL ASTHMA THERAPEUTICS MARKET: SCORES
  • TABLE 123. GLOBAL ASTHMA THERAPEUTICS MARKET: BUSINESS STRATEGY
  • TABLE 124. GLOBAL ASTHMA THERAPEUTICS MARKET: PRODUCT SATISFACTION
  • TABLE 125. GLOBAL ASTHMA THERAPEUTICS MARKET: RANKING
  • TABLE 126. GLOBAL ASTHMA THERAPEUTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 127. GLOBAL ASTHMA THERAPEUTICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 128. GLOBAL ASTHMA THERAPEUTICS MARKET: MERGER & ACQUISITION
  • TABLE 129. GLOBAL ASTHMA THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 130. GLOBAL ASTHMA THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 131. GLOBAL ASTHMA THERAPEUTICS MARKET: INVESTMENT & FUNDING
  • TABLE 132. GLOBAL ASTHMA THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 133. GLOBAL ASTHMA THERAPEUTICS MARKET: LICENSE & PRICING
  • TABLE 134. GLOBAL ASTHMA THERAPEUTICS MARKET: CONTACT DETAILS
目次
Product Code: MRR-AB49FC1AB824

The Global Asthma Therapeutics Market size was estimated at USD 18.40 Billion in 2020 and expected to reach USD 20.08 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 9.47% to reach USD 31.68 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Asthma Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Class, the Asthma Therapeutics Market was studied across Anti-inflammatory, Bronchodilators, and Combination therapy.

Based on Product, the Asthma Therapeutics Market was studied across Inhalers and Nebulizers. The Inhalers is further studied across Dry powder inhalers, Metered-dose inhalers, and Soft mist inhalers.

Based on Route of administration, the Asthma Therapeutics Market was studied across Inhaled and Oral.

Based on Geography, the Asthma Therapeutics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Asthma Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Asthma Therapeutics Market, including Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Biogen Inc., Boehringer Ingelheim GmbH, CareFusion Corporation, Convexity Scientific Inc, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Kare Medical and Analytical Devices Ltd. Co., Merck & Co. Inc., Merxin Ltd, Mylan N.V., Novartis AG, Parekhplast India Ltd, Philips Healthcare, Regeneron Pharmaceuticals, Inc, Roche Diagnostics, Sanofi-Aventis SA, Shenzhen Aeon Technology, Softhale NV, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Trudell Medical Limited (AeroEclipse), and Well Lead Medical Co.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Asthma Therapeutics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Asthma Therapeutics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Asthma Therapeutics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Asthma Therapeutics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Asthma Therapeutics Market?
  • 6. What is the market share of the leading vendors in the Global Asthma Therapeutics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Asthma Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Drug Class Outlook
  • 3.5. Route of administration Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of asthma and other respiratory diseases
      • 5.1.1.2. Recent improvements in the diagnostic technologies
      • 5.1.1.3. Extensive demand for monoclonal antibodies (mAbs)
    • 5.1.2. Restraints
      • 5.1.2.1. Limitation and side effects of the asthma therapeutics devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of combination therapeutics for the treatment
      • 5.1.3.2. Increasing healthcare expenditures and extensive R&D efforts
    • 5.1.4. Challenges
      • 5.1.4.1. Limited therapeutics reach in remote areas
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Asthma Therapeutics Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Anti-inflammatory
  • 6.3. Bronchodilators
  • 6.4. Combination therapy

7. Asthma Therapeutics Market, by Product

  • 7.1. Introduction
  • 7.2. Inhalers
    • 7.2.1. Dry powder inhalers
    • 7.2.2. Metered-dose inhalers
    • 7.2.3. Soft mist inhalers
  • 7.3. Nebulizers

8. Asthma Therapeutics Market, by Route of administration

  • 8.1. Introduction
  • 8.2. Inhaled
  • 8.3. Oral

9. Americas Asthma Therapeutics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Asthma Therapeutics Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Asthma Therapeutics Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. Amgen Inc.
  • 13.3. AstraZeneca Plc
  • 13.4. Biogen Inc.
  • 13.5. Boehringer Ingelheim GmbH
  • 13.6. CareFusion Corporation
  • 13.7. Convexity Scientific Inc
  • 13.8. F. Hoffmann-La Roche AG
  • 13.9. GlaxoSmithKline plc.
  • 13.10. Kare Medical and Analytical Devices Ltd. Co.
  • 13.11. Merck & Co. Inc.
  • 13.12. Merxin Ltd
  • 13.13. Mylan N.V.
  • 13.14. Novartis AG
  • 13.15. Parekhplast India Ltd
  • 13.16. Philips Healthcare
  • 13.17. Regeneron Pharmaceuticals, Inc
  • 13.18. Roche Diagnostics
  • 13.19. Sanofi-Aventis SA
  • 13.20. Shenzhen Aeon Technology
  • 13.21. Softhale NV
  • 13.22. Sunovion Pharmaceuticals, Inc.
  • 13.23. Teva Pharmaceutical Industries Ltd.
  • 13.24. Trudell Medical Limited (AeroEclipse)
  • 13.25. Well Lead Medical Co

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details